Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $1,773 - $2,837
11 New
11 $2,000
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $9,620 - $12,815
-58 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $51.5 Million - $64.6 Million
-285,720 Reduced 99.98%
58 $11,000
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $8.31 Million - $11.6 Million
-56,134 Reduced 16.42%
285,778 $54.8 Million
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $795,334 - $1.03 Million
6,492 Added 1.94%
341,912 $50.4 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $2.75 Million - $4.09 Million
29,131 Added 9.51%
335,420 $41.5 Million
Q1 2020

May 15, 2020

BUY
$84.96 - $109.14 $2.6 Million - $3.34 Million
30,614 Added 11.11%
306,289 $29.6 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $7.75 Million - $9.76 Million
-104,903 Reduced 27.56%
275,675 $25.5 Million
Q3 2019

Nov 13, 2019

BUY
$76.65 - $95.51 $7.5 Million - $9.34 Million
97,839 Added 34.6%
380,578 $29.2 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $15.3 Million - $24.3 Million
282,739 New
282,739 $24.3 Million
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $8,252 - $11,778
-171 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$46.8 - $58.97 $1,216 - $1,533
-26 Reduced 13.2%
171 $9,000
Q2 2018

Aug 14, 2018

BUY
$35.26 - $47.04 $528 - $705
15 Added 8.24%
197 $9,000
Q3 2017

Nov 14, 2017

SELL
$36.98 - $46.06 $1,516 - $1,888
-41 Reduced 18.39%
182 $7,000
Q2 2017

Aug 14, 2017

BUY
N/A
223
223 $9,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.